Lipitor

Atorvastatin, the active ingredient in Lipitor, is a HMG‑CoA reductase inhibitor presented as a tablet for oral use. It lowers elevated cholesterol levels and is used to reduce the risk of cardiovascular disease in adult patients with hypercholesterolemia.

GNH USA supplies Lipitor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Atorvastatin (Lipitor) is indicated for disorders of lipid metabolism and related cardiovascular risk reduction.

- Hypercholesterolemia: lowers total and LDL‑cholesterol to target levels. - Primary prevention of cardiovascular disease: reduces incidence of heart attack and stroke in at‑risk adults. - Secondary prevention of cardiovascular events: helps prevent recurrent myocardial infarction or stroke after an initial event.

Atorvastatin may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Myalgia: muscle aches without weakness. - Gastrointestinal discomfort: nausea, abdominal pain or dyspepsia. - Elevated liver enzymes: mild transaminase increase. - Fatigue: general tiredness. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Rhabdomyolysis: severe muscle breakdown with possible renal impairment. - Hepatotoxicity: significant elevation of liver transaminases or hepatitis. - Acute renal failure: rare cases linked to muscle injury. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - New onset diabetes: modest increase in blood glucose levels. - Cognitive impairment: rare reports of memory loss or confusion.

Before initiating therapy, consider the following safety measures.

- Liver function monitoring: assess baseline transaminases and repeat periodically. - Muscle symptom vigilance: educate patients to report unexplained muscle pain or weakness. - Drug interactions: review concomitant medications that may increase statin exposure. - Pregnancy and lactation: avoid use unless clearly indicated by a physician. - Renal impairment: adjust therapy in patients with severe kidney disease. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Atorvastatin can interact with several drug classes, influencing its efficacy and safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): may cause toxic statin levels. - Gemfibrozil: increases risk of myopathy and rhabdomyolysis. - Cyclosporine: elevates atorvastatin plasma concentrations.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce absorption. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Digoxin: potential increase in serum digoxin levels. - Niacin: combined therapy may raise risk of muscle toxicity. - Certain HIV protease inhibitors: may modestly increase statin exposure.